ContraFect Corp. Daily Stock Analysis

Daily Stock Analysis, CFRX, ContraFect Corp, priceseries

ContraFect Corp. Daily Stock Analysis
Stock Information
Open
3.27
Close
3.12
High
3.35
Low
3.12
Previous Close
3.30
Daily Price Gain
-0.18
YTD High
3.44
YTD High Date
Mar 4, 2022
YTD Low
2.11
YTD Low Date
Jan 24, 2022
YTD Price Change
0.28
YTD Gain
9.86%
52 Week High
7.63
52 Week High Date
Mar 12, 2021
52 Week Low
2.11
52 Week Low Date
Jan 24, 2022
52 Week Price Change
-1.60
52 Week Gain
-33.90%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 15. 2017
17.50
Mar 1. 2017
20.96
9 Trading Days
19.74%
Link
LONG
Sep 27. 2017
10.20
Oct 11. 2017
11.43
10 Trading Days
12.02%
Link
LONG
Jan 3. 2018
10.30
Jan 17. 2018
11.38
9 Trading Days
10.49%
Link
LONG
Jan 26. 2018
12.50
Feb 9. 2018
14.77
10 Trading Days
18.20%
Link
LONG
May 4. 2018
15.70
Jun 5. 2018
19.05
21 Trading Days
21.31%
Link
LONG
Jun 14. 2018
20.00
Jun 25. 2018
22.34
7 Trading Days
11.69%
Link
LONG
Jul 6. 2018
24.40
Jul 17. 2018
25.83
7 Trading Days
5.85%
Link
LONG
Sep 24. 2018
18.10
Oct 5. 2018
19.81
9 Trading Days
9.42%
Link
LONG
Oct 29. 2018
19.50
Nov 12. 2018
20.82
10 Trading Days
6.76%
Link
LONG
Jun 11. 2019
5.05
Jun 12. 2019
5.33
1 Trading Days
5.45%
Link
LONG
Sep 10. 2019
3.60
Sep 25. 2019
3.84
11 Trading Days
6.69%
Link
LONG
Nov 18. 2019
3.20
Nov 26. 2019
3.50
6 Trading Days
9.63%
Link
LONG
Dec 12. 2019
3.33
Dec 20. 2019
4.02
6 Trading Days
20.77%
Link
LONG
Dec 23. 2019
4.38
Jan 27. 2020
10.21
22 Trading Days
132.93%
Link
LONG
Feb 13. 2020
8.28
Feb 26. 2020
10.21
8 Trading Days
23.28%
Link
LONG
Apr 9. 2020
5.94
Apr 21. 2020
6.33
7 Trading Days
6.48%
Link
LONG
Apr 22. 2020
6.97
Apr 23. 2020
7.36
1 Trading Days
5.60%
Link
LONG
Jun 15. 2020
5.77
Jun 29. 2020
6.64
10 Trading Days
15.00%
Link
LONG
Feb 8. 2021
5.89
Feb 19. 2021
6.22
8 Trading Days
5.57%
Link
LONG
Feb 4. 2022
2.75
Mar 3. 2022
3.24
18 Trading Days
17.66%
Link
Company Information
Stock Symbol
CFRX
Exchange
NasdaqCM
Company URL
http://www.contrafect.com
Company Phone
914-207-2300
CEO
Steven C. Gilman
Headquarters
New York
Business Address
28 WELLS AVENUE, 3RD FLOOR, YONKERS, NY 10701
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001478069
About

ContraFect Corp. is a clinical-stage biotechnology company. It focuses on discovering and developing therapeutic protein and antibody products for the treatment of life-threatening infectious diseases, including those caused by drug-resistant pathogens, particularly those treated in hospital settings. The company scientific and clinical strategy focuses on the use of combination therapies. ContraFect was founded by Robert Nowinski on March 5, 2008 and is headquartered in Yonkers, NY.

Description

ContraFect Corporation, a clinical-stage biotechnology company, focuses on discovering and developing therapeutic protein and antibody products for the treatment of life-threatening infectious diseases in the United States. Its lead product candidates consist of CF-301, a lysin that completed Phase 1 human clinical trials for the treatment of Staph aureus bacteremia, including endocarditis caused by methicillin-resistant or methicillin-susceptible Staph aureus; and CF-404, a combination of human monoclonal antibodies (mAbs) for the treatment of life-threatening seasonal and pandemic varieties of human influenza. The company has a collaboration research agreement with The Rockefeller University to identify new lysin therapeutic candidates targeting Gram-negative bacteria; and license agreement with Trellis Bioscience LLC for mAbs in the field of influenza. ContraFect Corporation was founded in 2008 and is headquartered in Yonkers, New York.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading